The ability to differentiate regional patterns of flow and metabolism between various patient populations depends upon the signal-to-noise characteristics of the data. The approach chosen for producing quantitative data will affect the detection sensitivity of a method.
Functional imaging with positron emission to mography (PET) is a unique tool for investigation of normal physiology and pathology in the human brain. Studies with e50]water and eSF]deoxyglu cose (FDG) using state-of-the-art scanners define the three-dimensional distribution of cerebral blood flow and glucose metabolism. When studying a dis order where the physiological signal is large, as in epilepsy or brain tumors, abnormalities may be de tected in the image data from a single patient. How ever, in most studies, biological signals obtained with flow and metabolism tracers are small and complex, as in some stimulation studies of the nor mal brain or in certain brain disorders. Typically, population studies with many subjects are required to detect changes reliably in specific brain regions or changes in patterns of regional flow or metabo lism. If the signal is small, successful differentiation of patient populations depends upon the magnitude of the noise. In PET studies, noise includes (a) in herent biological variability in the populations un der study, (b) errors due to instrumentation and re-construction, (c) physiological quantitation inaccu racies, and (d) errors in extraction of regional information from the image data. This discussion considers the third source of error, physiological quantitation, i.e., the application of a mathematical model to determine local physiological parameters from PET radioactivity measurements. This discus sion will focus primarily on FDG and e50]water methods. It is often useful to adopt simpler procedures for clinically oriented protocols than those used in the original modeling studies. Based on the understand ing of the tracer provided by the model, study con ditions (tracer administration scheme, scanning and blood data collection, and data processing) can be A46 R.E.CARSON defined to measure one or more physiological pa rameters such as glucose metabolic rate. If the methods are chosen appropriately, the accuracy of the final physiological measurements will be com parable to those obtained from the more complex modeling studies (e.g., Sokoloff et aI., 1977; Huang et aI., 1980) . In this way, model-based methods promise to produce unbiased or minimally biased estimates of the physiological parameter(s) on a re gional or pixel-by-pixel basis.
Empirical methods are alternatives to model based methods. Such approaches make no explicit attempt to estimate the physiological parameter(s) of interest, but rather use an index that is presumed to reflect the underlying physiology. Empirical in dices include absolute radioactivity values, radioac tivity values corrected for dose and subject weight, or ratios of radioactivity values to whole brain or to a standard region's value (normalized values). In general, model-based methods have one important advantage over empirical approaches, an advantage that is realized when significant regional differences in metabolism are detected. If differences are de tected using a model-based method, it is much more acceptable to attribute them to differences in the VarIatIOn in the populations under study that the model removes versus the accuracy of the model and the reliability of the additional measurements required by the model.
SOURCES OF ERROR IN

MODEL-BASED METHODS
Errors introduced by the modeling process orig inate from the following areas.
The model itself
Every mathematical model used in PET is an oversimplification of the underlying physiology that determines the delivery, uptake, and metabolism of a tracer. For example, most PET models treat the tissue data as if it arises from a perfectly homoge neous region. In addition, it is assumed that the physiological parameters remain constant during the entire data collection period. Despite these and many other limitations, well-designed models pro vide parameter estimates that are closely related to their physiological definitions. Validation studies are necessary to demonstrate the exact form of these relationships. Comprehensive validation stud ies have not been performed for most models and methods, partly because "gold standards" of re gional physiology are difficult to obtain to validate in vivo measurements made with PET.
Assumed model parameters
Since most models have more parameters than can be estimated in practice, some assumptions are usually required. For example, for all FDG studies, a lumped constant value is required. In addition, for all single-scan FDG approaches (Huang et aI., 1980; Brooks, 1982; Hutchins et aI., 1984) , population values for the rate constants are used to estimate the cerebral glucose metabolic rate (CMR g lc). Each estimate of CMR g lc using one of these operational equations will be biased. The magnitude of the bias depends on the scan time, the input function, and the actual values of the local rate constants and lumped constant. The effects of errors in these pa rameters have been analyzed and the operational equations have been designed to minimize their im pact. If the rate constants used in a given opera tional equation are the true average values for the population being studied, the average bias will be nearly zero, but the use of average rate constants will contribute to intersubject variability. If the met abolic rate is determined from rate constants esti mated from dynamic data acquisition, these biases can be avoided but at the price of a more compli cated study. The increased potential for patient mo-PHYSIOLOGICAL QUANT/TAT/ON IN PET A47 tion during prolonged kinetic studies, however, is a cause for increased error using this approach.
The input function
Accurate measurement of the input function to the brain is usually an essential component of model-based methods. Typically, the blood curve is measured in a peripheral (usually radial artery) blood vessel. There are many possible sources of error in this determination. Blood samples must be taken at a sufficiently rapid rate to characterize the curve accurately. For single-scan FDG studies, a slower infusion of tracer over I min or more can reduce the need for extremely rapid sampling with out altering the accuracy of the method. For dy namic FDG studies, the optimal strategy for tracer administration depends upon the handling of the data in the first few minutes when blood activity contributes substantially to the tissue measure ments (Evans et aI., 1986; Hawkins et aI., 1986) . In all input function measurements, careful attention is required for accurate sample timing, centrifugation, pipetting or weighing, radioactivity counting, counting corrections (background, decay, dead time, etc.), and ·data handling. Quality control con siderations are important in order to collect and process input functions accurately and reliably as studies become more routine. Dynamic FDG stud ies involving estimation of the rate constants are more sensitive to inaccuracies in the measurement of the input function than single-scan methods.
Other sources of errors related to the input func tion include the use of arterialized venous or venous rather than arterial blood (Phelps et aI., 1979) , tim ing and dispersion differences between the brain and the peripheral artery (an important effect for bolus CBF studies), and scanner-gamma counter calibration. Errors in this last term usually apply a scale factor error to the results, which may vary from slice to slice.
Associated blood measurements
The plasma glucose measurement for FDG stud ies applies a scale factor to the entire patient study.
Random errors in this measurement contribute to intersubject variability.
ERROR ANALYSIS
Many investigators have examined the impact of these and other error sources on PET estimates of glucose metabolism (e.g., Huang et aI., 198 1; Brownell et aI., 1983; Weinhard et aI., 1985; Jagust et aI., 1986 ) and blood flow (e.g., Huang et aI., 1979; Lammertsma et aI., 198 1, 1982; Herscovitch et aI., 1983; Koeppe et aI., 1985 Koeppe et aI., , 1987 Iida et aI., 1988) . Such analyses pre dict that an error of x% in a given measurement or assumption will result in a y% error in the final re sult. Error analyses are useful in comparing various methods or in optimizing protocol parameters. Un fortunately, it is difficult to assess the total error of a method from the errors in a number of measure ments or assumptions. First, the error sources are not independent, and their covariance structure is not usually known. For example, while the effects of errors in the rate constants in single-scan FDG studies have been defined (Huang et aI., 1980; Brooks, 1982; Hutchins et aI., 1984) , these con stants will covary from region to region and subject to subject. The resulting errors may be larger or smaller than that predicted by a root-mean-square calculation that would be appropriate for indepen dent error sources. A second limitation in estimat ing the magnitude of the error in model-based meth ods is that the actual size of the errors in the mea surements or assumptions are rarely known and difficult to determine. Therefore, it is very difficult to predict the errors associated with physiological quantitation in PET. One approach to assess the impact of some of these errors is to examine the reproducibility of a method (Reivich et aI., 1982; Duara et aI., 1987; Bartlett et aI., 1988) . Reproduc ibility can also be used as a figure of merit to choose between various analysis methods applied to the same data (Carson et aI., 1987) .
A similar approach can be taken with population data to determine whether a model-based method has superior signal-to-noise characteristics than a simpler empirical method for data reduction. For example, for single-scan FDG studies, local radio activity expressed as percent of injected dose/kg could be used as an index instead of CMR g 1c-Cor rections could be applied for plasma glucose con centrations from arterial or venous samples. Data from a large number of subjects could be analyzed in multiple ways to determine the approach that maximizes the statistical power to differentiate pat terns of metabolism. One important consideration in using a more empirical measure is the physiolog ical condition of the patients under study. If phys iological variations occur, an empirical method may produce misleading results if it is inappropriately interpreted as showing changes in regional metabo lism. For example, if plasma tracer clearance differs between patients and control subjects, substantial errors may be made by interpreting radioactivity values as reflecting metabolism. If empirical mea sures are interpreted conservatively, they may pro vide very useful tools for comparing populations. It is equally important to remember that model-based methods rely on many assumptions that can pro duce misleading results when applied inappropri ately. For example, in ischemic tissue, the FDG rate constants and the lumped constant differ from normal (Hawkins et aI., 198 1; Gjedde et aI., 1985; Nakai et aI., 1987) . 1980). One of the operational equations used to pre dict the CMRglc can be written in the form where Cp is the plasma glucose concentration and LC is the lumped constant (Brooks, 1982) . When the normalized metabolic rate (NMR) is calculated, if the normalization region was scanned at the same time as the region of interest, the formula simplifies dramatically: (1984) is used, the results will be identical.
If mUltiple scans at different anatomical levels are performed, the terms in the operational equation will have slightly different values to account for dif ferent scan times postinjection. With earlier scan ners having one or only a few slices, these model corrections were significant because long total scan times were required to sample the entire brain. With the current generation of scanners with 15 or more slices, the entire brain can be examined with one or two scans, and the variation in model correction factors between slices is smaller.
In single scan methods for measurement of CMRglc with PET, the calculated value for CMR glc is linearly related to the concentration data, so it is fairly straightforward to consider the effects of nor malization. Bolus injection methods for CBF (Holden et aI., 198 1; Huang et aI., 1982; Herscov itch et aI., 1983; Alpert et aI., 1984; Carson et aI., 1986 ) have a more complex relationship between flow and the tissue radioactivity measurement(s).
These methods effectively apply a contrast en hancement to the images. By limiting data collec tion to the first 40-60 s postinjection, the nonlinear-
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A49 ity of the raw concentration data with respect to CBF is small, and these images are useful for ap proximating relative flow (Herscovitch et aI. , 1983; Fox et aI. , 1984; Mazziotta et aI. , 1985) . These ap proaches work particularly well when multiple stud ies are performed in the same subject and intra subject comparisons are of prime interest. Are the advantages of model-based methods worth the .additional effort? How many more pa tients could be studied with a simpler procedure that did not require blood sampling? Also, how im portant is physiological quantitation for funding and publication? There are no general answers to these questions. The utility of a model-based method de pends on the biological question under study, the tracer and its model, and the patient populations. It is essential to have a good understanding of the re lationship between the PET tissue measurements and the underlying physiology, i. e. , a model. With out a model, it is difficult to assess how physiolog-ical differences between study populations affect an empirical method. However, for well-understood tracers with well-defined models, tracer administra tion and data acquisition parameters can be de signed appropriately to permit a simple empirical technique to be used successfully in many patient populations. In such cases, the signal-to-noise im provement gained by applying model-based meth ods to the task of differentiating physiological pat terns in multiple populations may be small. Im provements in instrumentation, reconstruction techniques, and structure identification and reduc tions in patient motion are more likely to increase statistical power to identify differences in flow and metabolism. However, even when the underlying model is well worked out, great care must be used to avoid misinterpretation of results with empirical methods, particularly when the patient popUlations have different physiological traits than the controls.
